No Data
No Data
HSBC Adjusts Amgen Price Target to $357 From $385, Maintains Buy Rating
Express News | Sandoz CEO: Generic Drugmakers Meeting White House Officials Nearly Every Week Amid Supply Security Concerns
Express News | Sandoz CEO: Drugmakers' Proposal on Europe-Wide List Price for New Medicines Is "Deeply Flawed", Would Not Solve Global Pricing Inequities
HSBC Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $357
Express News | Amgen Inc : HSBC Cuts Target Price to $357 From $385
No Misses Here: Healthcare Earnings Sweep Past Wall Street Estimates